Should You Buy Allstate Corp (ALL) Today? Analysis, Price Targets, and 2026 Outlook.
Analysis Updated At
2026/01/28
ALL is NOT a good buy right now for a beginner long-term investor who wants to enter immediately. The stock’s technical trend is bearish (downtrend across key moving averages) and near-term catalysts skew negative (winter-storm claims risk + industry pricing/competition softening). While Allstate’s latest quarter showed very strong profitability recovery and Wall Street price targets remain above the current price, the current setup favors waiting rather than buying into weakness today.
Technical Analysis
Price/trend: Bearish. Moving averages are stacked negatively (SMA_200 > SMA_20 > SMA_5), indicating the broader trend is down and rallies may face selling pressure.
Momentum: MACD histogram is -0.75 (below zero) and only “negatively contracting,” which suggests downside momentum is still present, though possibly stabilizing.
RSI: RSI(6) ~38.75—near the lower end of neutral and close to “oversold-ish,” but not a clear reversal signal.
Levels: Pivot 198.69 is overhead (near-term resistance). Nearest support S1 is 191.44 (close to current ~194.8), then S2 186.97. Resistance levels are R1 205.94 and R2 210.41. With price below the pivot and close to support, risk of a support test remains elevated.
Analyst Ratings and Price Target Trends
Recent trend: Mixed to slightly more cautious. Several firms cut price targets in early Jan 2026 (Evercore to $225; Goldman to $227) while maintaining ratings (In Line / Buy), reflecting tougher cyclical expectations. There were also notable downgrades in Dec 2025 (William Blair to Market Perform; Morgan Stanley to Equal Weight with PT $215) citing deteriorating auto fundamentals and a clearer path to a more challenging year. Offsetting this, some bullish voices remain and targets can be high (BofA Buy with PT $313; KBW Outperform with PTs around $250+).
Wall Street pros/cons: Pros—profitability rebound, still generally favorable targets vs current price, potential capital return/earnings execution. Cons—P&C cycle softening, auto loss cost pressure, catastrophe/event risk.
Politicians/congress: No recent congress trading data available. Hedge funds/insiders: Neutral (no notable recent trend).
Wall Street analysts forecast ALL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ALL is 238.35 USD with a low forecast of 201 USD and a high forecast of 313 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Wall Street analysts forecast ALL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ALL is 238.35 USD with a low forecast of 201 USD and a high forecast of 313 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Current: 197.330
Current: 197.330
